ASSOCIATION OF PERIPHERAL NEUROPATHY WITH SYMPTOMS OF BURNING MOUTH SYNDROME IN TYPE II DIABETIC PATIENTS
Main Article Content
Keywords
DPN, BMS, Type-II DM, Symptoms
Abstract
Objective: The purpose of this study was to investigate whether or not there is a connection between experiencing symptoms similar to burning mouth syndrome and having diabetic peripheral neuropathy.
Study Design: Cross-sectional study
Place and Duration: Department of Oral Pathology, Baqai Medical University, Karachi/ Sardar Begum Dental College and Hospital, Rehman College of Dentistry, Peshawar KPK, Pakistan from May 2022-April-2023.
Methods: Total 215 patients of both genders with type-II DM were presented. We asked patients to fill out a detailed medical history questionnaire that included their age, gender, height, weight, occupation, method of therapy, HbA1c, diabetic status, if they had DPN, and whether they had any BMS symptoms. SPSS 23.0 was used to analyze all data.
Results: Out of the total, 125 patients (58.1%) displayed symptoms similar to BMS, while 90 patients (41.9%) did not. Age, treatment regimen, time since diagnosis, Hb1AC, diabetic status, DPN of hands and feet, and form of peripheral neuropathy were found to be statistically significantly related to the occurrence of BMS. Binary logistic regression study identified diabetes status, peripheral neuropathy of the hands, and peripheral neuropathy of the feet as three independent predictors of BMS.
Conclusion: The results of this study indicate that type II diabetic individuals are more likely to experience BMS-like symptoms if their diabetes is not well-controlled and if they have diabetic peripheral neuropathy (DPN) in their hands and feet.
References
2. Selvarajah D., Kar D., Khunti K., Davies M.J., Scott A.R., Walker J., Tesfaye S. Diabetic peripheral neuropathy: Advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7:938–948.
3. Sasso F.C., Carbonara O., Persico M., Iafusco D., Salvatore T., D’Ambrosio R., Torella R., Cozzolino D. Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: A randomized double-blind placebo-controlled crossover study. Diabetes Care. 2002;25:1909–1913.
4. Sasso F.C., Pafundi P.C., Gelso A., Bono V., Costagliola C., Marfella R., Sardu C., Rinaldi L., Galiero R., Acierno C., et al. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study. Nutr. Metab. Cardiovasc. Dis. 2019;29:923–930.
5. Braffett B.H., Gubitosi-Klug R.A., Albers J.W., Feldman E.L., Martin C.L., White N.H., Orchard T.J., Lopes-Virella M., Lachin J.M., Pop-Busui R., et al. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2020;69:1000–1010.
6. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., Nuber A., Pozza G., Ward J.D. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–1384.
7. Andersen S.T., Witte D.R., Dalsgaard E.-M., Andersen H., Nawroth P., Fleming T., Jensen T.M., Finnerup N.B., Jensen T.S., Lauritzen T., et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care. 2018;41:1068–1075.
8. Sasso F.C., Salvatore T., Tranchino G., Cozzolino D., Caruso A.A., Persico M., Gentile S., Torella D., Torella R. Cochlear dysfunction in type 2 diabetes: A complication independent of neuropathy and acute hyperglycemia. Metabolism. 1999;48:1346–1350.
9. Papanas N., Ziegler D. Prediabetic neuropathy: Does it exist? Curr. Diabetes Rep. 2012;12:376–383.
10. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119.
11. Collin HL, Niskanen L, Uusitupa M, Toyry J, Collin P, Koivisto AM, et al. Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2000;90:299–305.
12. Langlois V, Bedat Millet AL, Lebesnerais M, Miranda S, Marguet F, Benhamou Y, et al. Small fiber neuropathy. La Revue de medecine interne. 2018;39:99–106.
13. Dixit S, Maiya A. Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review. J Postgrad Med. 2014;60:33–40.
14. Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10:8.
15. Collin HL, Niskanen L, Uusitupa M, Toyry J, Collin P, Koivisto AM, et al. Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2000;90:299–305.
16. A nada, Abdel Moneim W, Fakhr M, El Sawy S. Prevalence of Burning Mouth Syndrome in A sample of Egyptian Patients with Diabetic Neuropathy: A Cross Sectional Hospital-Based Study. Advanced Dental Journal. 2020;2:34–42.
17. Patel M, Patel IM, Patel YM, Rathi SK. A hospital-based observational study of type 2 diabetic subjects from Gujarat, India. J Health Popul Nutr. 2011;29:265–72.
18. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.
19. Kim MJ, Kho HS. Understanding of Burning Mouth Syndrome Based on Psychological Aspects. The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA). 2018;21:9–19.
20. Moore PA, Guggenheimer J, Orchard T. Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. Journal of diabetes and its complications 2007;21:397–402.
21. Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, Di Salvo J, Epifani R, Piacevole A, Tagliaferri G, Rocco M, Iadicicco I, Docimo G, Rinaldi L, Sardu C, Salvatore T, Marfella R, Sasso FC. Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. Int J Mol Sci. 2023 Feb 10;24(4):3554.
22. Karlsson P., Provitera V., Caporaso G., Stancanelli A., Saltalamacchia A.M., Borreca I., Manganelli F., Santoro L., Jensen T.S., Nolano M. Increased peptidergic fibers as a potential cutaneous marker of pain in diabetic small fiber neuropathy. Pain. 2021;162:778–786.
23. Javed F, Thafeed Alghamdi AS, Mikami T, Mehmood A, Ahmed HB, Samaranayake LP, et al. Effect of glycemic control on self-perceived oral health, periodontal parameters, and alveolar bone loss among patients with prediabetes. Journal of periodontology 2014;85:234–41.
24. Gibson J, Lamey PJ, Lewis M, Frier B. Oral manifestations of previously undiagnosed non-insulin dependent diabetes mellitus. Journal of oral pathology & medicine 1990;19:284–7.
25. Park JH, Won JC. Patterns of Nerve Conduction Abnormalities in Patients with Type 2 Diabetes Mellitus According to the Clinical Phenotype Determined by the Current Perception Threshold. Diabetes Metab J 2018;42:519-28.
26. Azmi S, ElHadd KT, Nelson A, et al. Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review. Diabetes Ther 2019;10:35-56.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Nimra Noreen
Lecturer, Department of Oral Pathology, Baqai Medical University, Karachi Pakistan
Saman Shamshad
BDS/ M.Phil Oral Pathology, Sardar Begum Dental College and Hospital, Gandhara University, Peshawar Pakistan
Maleeha Hadi
BDS/ M.Phil Oral Pathology, Sardar Begum Dental College and Hospital, Gandhara University, Peshawar Pakistan
Farkhanda Jabeen
BDS/ M.Phil Oral Pathology, Sardar Begum Dental College and Hospital, Gandhara University, Peshawar Pakistan
Mahnoor Ibrar
Lecturer, Department of Pathology, Kabir Medical College, Gandhara University, Peshawar Pakistan
Gulmeena Masood
Lecturer, Department of Oral Pathology, Rehman College of Dentistry, Peshawar Pakistan